NLM DIR Seminar Schedule
UPCOMING SEMINARS
-
Oct. 20, 2026 Devlina Chakravarty
Toward Reliable Amyloid Assembly Prediction -
Oct. 27, 2026 Bayarbaatar Amgalan
TBD -
Nov. 3, 2026 Joseph Thole
TBD -
Nov. 10, 2026 Reserved
TBD -
Nov. 17, 2026 Reserved
TBD
RECENT SEMINARS
-
Oct. 13, 2026 Ryan Bell
Satellite Phage Integrated Defensive and Ecotypic Replicons (SPIDERs). -
Oct. 6, 2026 Roman Kogay
Beyond canonical architectures: exploring hidden variation of prokaryotic defense systems -
June 30, 2026 Jaya Srivastava
Disrupted Regulation of Essential Genes Mediates Dementias and Age-Associated Disorders -
June 11, 2026 Angela Jiang
Identification and Evolutionary Analysis of Steroid-Metabolism Enzymes in Gut Microbes -
June 10, 2026 Luda Diatchenko
New Insights on Pain Biology from Human Transcriptomics: How Stimulation of Immune Response Shapes Pain Resolution
The NLM DIR holds a public weekly seminar series for NLM trainees, staff scientists, and investigators to share details on current and exciting research projects at NLM. Seminars take place on Tuesdays at 11:00 AM, EST and some Thursdays at 3:00 PM, EST. Seminars are held in the B2 Library of Building 38A on the main NIH campus in Bethesda, MD.
To schedule a seminar, click the “Schedule Seminar” button to the right, select an appropriate date on the calendar to sign up, and then complete the form. You will need an NIH PIV card to access the “Schedule Seminar” page.
Please include seminars by invited visiting scientists in the NLM DIR seminar series. These need not be on a Tuesday or Thursday.
If you would like to schedule a seminar by a visiting scientist, click the “Schedule Seminar” and complete the form. Contact NLMDIRSeminarScheduling@mail.nih.gov with questions. Please follow this link to subscribe/unsubscribe to/from the NLM DIR seminar mailing list.
Titles and Abstracts for Upcoming Seminars
(based on the current date)
Toward Reliable Amyloid Assembly Prediction
Across diverse organisms, evolution has harnessed tightly regulated amyloid formation for important biological functions, and this process is also associated with various human diseases1. Reliable structure prediction could reveal how sequence and environment determine fibril architecture and prioritize assembly formation. Amyloid fibrils remain challenging because their repetitive assemblies are polymorphic: predictions may reproduce local beta-rich structure while missing the full assembly, and comparison with a single experimental structure may misclassify an alternative polymorph as a failure. We benchmarked five predictors—AlphaFold 32 with/without templates, Boltz-23, ColabFold4, and ESMFold25—on 90 experimental targets6, sampling 25 predictions per condition (11,250 models). We searched the benchmark and Amyloid Atlas⁶ for known polymorphs and evaluated partial matches separately. Across methods, 38 targets (42.2%) had at least one full-assembly recovery, 8 (8.9%) had only partial or subassembly recovery, and 44 (48.9%) had neither. Known-polymorph searches added only two full-assembly recoveries, suggesting that most failures reflect an inability to recover known higher-order organization rather than selecting a documented alternative polymorph. Combining local-structure and interface confidence—(i) mean pLDDT (predicted Local Distance Difference Test) and (ii) ipTM (interface predicted TM-score)—enriched for correct assemblies, but some high-confidence predictions still had incorrect topologies or interfaces. Among 88 energy-matched targets, stabilization energy per molecule⁶ was moderately associated with recovery class (Spearman ρ=0.49) but did not distinguish recovered from unrecovered assemblies. These results motivate a reference-free framework integrating geometry, energetics, and calibrated confidence to identify amyloid-compatible predictions.
Reference:
1. Fowler DM et al. Trends Biochem Sci. 2007; 32:217–224.
2. Abramson J et al. Nature. 2024; 630:493–500.
3. Passaro S et al. bioRxiv. 2025.
4. Mirdita M et al. Nat Methods. 2022; 19:679–682.
5. Candido S et al. bioRxiv. 2026.
6. Sawaya MR et al. Cell. 2021; 184:4857–4873.
TBD
TBD
TBD
TBD